Zai Lab Operating Income 2016-2022 | ZLAB
Zai Lab operating income from 2016 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Zai Lab Annual Operating Income
(Millions of US $) |
| 2021 |
$-700 |
| 2020 |
$-302 |
| 2019 |
$-203 |
| 2018 |
$-142 |
| 2017 |
$-51 |
| 2016 |
$-39 |
| 2015 |
$-16 |
Zai Lab Quarterly Operating Income
(Millions of US $) |
| 2022-03-31 |
$-80 |
| 2021-12-31 |
$-219 |
| 2021-09-30 |
$-83 |
| 2021-06-30 |
$-171 |
| 2021-03-31 |
$-227 |
| 2020-12-31 |
$-95 |
| 2020-09-30 |
$-76 |
| 2020-06-30 |
|
| 2020-03-31 |
$-46 |
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.334B |
$0.144B |
|
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
|
